PLx Pharma

$2.23 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About PLx Pharma

PLx Pharma, Inc. is a late-stage specialty pharmaceutical company developing aspirin products that use its patented drug delivery system, which targets delivery of APIs to various portions of the gastrointestinal tract. This has the potential to improve the absorption of many drugs and to reduce acute GI side effects associated with aspirin and ibuprofen, and potentially other drugs.

Stock Analysis

last close $2.32
1-mo return -1.7%
3-mo return -44.5%
avg daily vol. 178.32T
52-week high 21.5
52-week low 1.81
market cap. $64M
forward pe -
annual div. -
roe -138.1%
ltg forecast -
dividend yield -
annual rev. $10M
inst own. 41.5%

Subscribe now for daily local and international financial news